Drugs / Novel oral poliomyelitis vaccine type 2 (nOPV2)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06137664 | Nov 2024 → Dec 2027 expected | poliomyelitis | PATH | Recruiting | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2020-11-16 | PT Bio Farma | Regulatory WHO Setujui Vaksin Pertama Keadaan Darurat Untuk Polio Type-2 co.id ↗
Badan Kesehatan Dunia (WHO) telah menyetujui penggunaan vaksin dalam keadaan darurat (Emergency Use Listing/ EUL) untuk jenis vaksin Polio pada tanggal 13 November 2020 |
All press releases naming this drug 2 releases
| Date | Issuer | Release |
|---|---|---|
| 2023-04-04 | PT Bio Farma | Vaksin nOPV2 Bio Farma: Percepat Pulihkan Indonesia dari Polio co.id ↗ |
| 2020-11-16 | PT Bio Farma | WHO Setujui Vaksin Pertama Keadaan Darurat Untuk Polio Type-2 co.id ↗ |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Novel oral poliomyelitis vaccine type 2 (nOPV2) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06137664 ↗ |
| Known as | nOPV2 | “Novel oral poliomyelitis vaccine type 2 (nOPV2)” NCT06137664 ↗ |
| Route | Oral | “Novel oral poliomyelitis vaccine type 2 (nOPV2)” NCT06137664 ↗ |